Research for new drug started at Yangji Chemical, a subsidiary of Han Wha, in 1987.
In order to support the research program, YANIKEM s.a.r.l was founded in France, cultivating researchers with global competence and Han Wha has established collaborative research system with academic institute to enhance the efficiency of research & development.
In 2007, R&D center moved into Gyeonggi Bio Center and since then the research has been carried out in an excellent surroundings.
Our researches are in pursuit of new drug, incrementally modified drug, specialized generics, and new functional food ingredient.
Cardiovascular Disorders
Endocrine Diseases
Respiratory Diseases
Digestion Diseases
Obstetrics & Gynecology Diseases
Musculoskeletal and Pain Disorders
Sustained Release
Multi-Layer Tablet
Extrusion &
Spheronization
Granulation
Pellet Coating
M-LAC Tech
MUL-CRAB Tech
Project | Research | Formulation | Pre-Clinical | Phase I | Phase II | Phase III | NDA / Launch |
YJF-008 (Respiratory System Disorders) |
|||||||
YJQ-101 (GI Tract System Disorders) |
|||||||
HWI-001 (Musculo-Skeletal Disorders/Peripheral Artery Diseases) |
|||||||
HWI-002 (Musculo-Skeletal Disorders) |
|||||||
HWO-001 (Cardiovascular Diseases + Endocrine Disorders) |
|||||||
HWO-002 (Endocrine Disorders) |
Project | Research | Formulation | Phase I | NDA / Launch |
YJF-009 (Respiratory System Disorders) |
||||
YJF-015 (Fever Reducer & Pain Reliever) |
||||
YJF-019 (Respiratory System Disorders) |
Project | Research | Pre-Clinical | Human Study | Certi / Launch |
NLH-001 (Antioxidant/Whitening) |
||||
NLH-002 (Antioxidant/Immune) |
* You can scroll left and right to see
NDA / Launch | ||||||
PhaseIII | ||||||
PhaseII | ||||||
PhaseI | ||||||
Pre-Clincial | ||||||
Formulation | ||||||
Research | ||||||
Project | YJF-008 (Respiratory System Disorders) |
YJQ-101 (GI Tract System Disorders) |
HWI-001 (Musculo-Skeletal Disorders/Peripheral Artery Diseases) |
HWI-002 (Musculo-Skeletal Disorders) |
HWO-001 (Cardiovascular Diseases + Endocrine Disorders) |
HWO-002 (Endocrine Disorders) |
* You can scroll left and right to see
NDA / Launch | |||
Phase I | |||
Formulation | |||
Research | |||
Project | YJF-009 (Respiratory System Disorders) |
YJF-015 (Fever Reducer & Pain Reliever) |
YJF-019 (Respiratory System Disorders) |
Certi / Launch | ||
Human Study | ||
Pre-Clinical | ||
Research | ||
Project | NLH-001 (Antioxidant/Whitening) |
NLH-002 (Antioxidant/Immune) |